Global Fertility Treatments Market Research Report 2021: Market Expected to Reach $21.7 Billion by 2025 at a CAGR of 8% – Long-Term Forecast to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “Global Fertility Treatments Market Report 2021: COVID-19 Growth and Trends to 2030” has been added to from ResearchAndMarkets.com offer.

The global fertility treatment market is expected to grow from $14.27 billion in 2020 to $15.74 billion in 2021 at a compound annual growth rate (CAGR) of 10.3%. The market is expected to reach $21.7 billion in 2025 with a CAGR of 8%.

Key players in the fertility treatment market are Apollo Hospitals Enterprise Ltd., Care Fertility Group, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, Progyny Inc., Vitrolife, Carolinas Fertility Institute, and OvaScience Inc. .

The fertility treatment market includes sales services and related products that are used in various applications to treat infertile patients. Fertility treatment is a medical procedure intended to increase the chances of conceiving a child.

The high cost and low success rate of in vitro fertilization (IVF) treatments is a major factor limiting the growth of the fertility treatment market. In vitro fertilization is a fertilization process in which an egg is fertilized with sperm outside the body, in vitro. The costs of in vitro fertilization (IVF) treatments differ in many countries due to the lack of reimbursement policies. Also, insurance companies generally do not cover infertility treatments.

According to the American Society of Reproductive Medicine, in the United States the average cost of an IVF cycle is $12,400 and the average cost of an IVF cycle using fresh embryos is $8,158 with a median cost of $7,500. The success rate of IVF treatments is only 28% to 35%, which decreases with increasing age of the woman. For example, for women, the success rate is 32.2% for those under 35 and 1.9% for women over 44. Thus, the high cost and low success rate of IVF treatment is limiting the growth of the fertility treatment market.

The growth in the median age of first childbearing combined with the change in lifestyle has increased the difficulty of conceiving, increasing the demand for fertility treatment. The median age of first childbearing has increased around the world due to later marriages, contraceptive techniques and the increase in the number of women who prioritize their careers over starting a family.

The development of new techniques to treat infertility using the human body is a key trend in the fertility treatment market.

Main topics covered:

1. Summary

2. Characteristics of the fertility treatment market

3. Fertility Treatments Market Trends and Strategies

4. Impact of COVID-19 on fertility treatments

5. Fertility Treatments Market Size and Growth

5.1. Global historical fertility treatment market, 2015-2020, billion dollars

5.1.1. Market Drivers

5.1.2. Market Constraints

5.2. Global Fertility Treatments Market Forecast, 2020-2025F, 2030F, Billion USD

5.2.1. Market Drivers

5.2.2. Market Constraints

6. Fertility Treatments Market Segmentation

6.1. Global Fertility Treatments Market, Segmentation by Product, History and Forecast, 2015-2020, 2020-2025F, 2030F, USD Billion

6.2. Global Fertility Treatments Market, Segmentation by End User, History and Forecast, 2015-2020, 2020-2025F, 2030F, USD Billion

• Fertility clinics

• Hospitals

• Surgical centers

• Clinical research institutes

6.3. Global Fertility Treatments Market, Segmentation by Patient Type, History and Forecast, 2015-2020, 2020-2025F, 2030F, USD Billion

7. Regional and Country Analysis of the Fertility Treatments Market

7.1. Global Fertility Treatments Market, Split by Region, Historical & Forecast, 2015-2020, 2020-2025F, 2030F, USD Billion

7.2. Global Fertility Treatments Market, Split by Country, Historical & Forecast, 2015-2020, 2020-2025F, 2030F, USD Billion

Companies cited

• Apollo Hospitals Enterprise Ltd.

• Fertility Care Group

• Genea Limited

• The Johns Hopkins Health System Company

• Medicover Group

• Monash IVF Group

• Progyny Inc.

• Vitrolife

• Carolinas Fertility Institute

• OvaScience Inc.

• Xytex Cryo France

• Merck KGaA

• Medical cook

• CooperSurgical Inc

• Bernabeu Institute

• INVO Biosciences

• Cooper Companies Inc.

• Virtus Health

• CryoChoice LLC

• Millendo Therapeutic Inc

• FUJIFILM Irvine Scientific

• LABOTEC GMBH

• Focus on fertility

• Olympus Society

• Irvine Scientific Sales Company Inc.

• Ferring Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/k49l1t